← 返回

通过胞啃作用从肿瘤细胞劫取 TYRO3 增强 NK 细胞效应功能与增殖

英文原题:Hijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation.

查看英文原题

Hijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation.

PubMed 2021/07/29(内容时间) Cancer Immunol Res Q1 · IF 7.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

细胞啃噬(trogocytosis)是指一个细胞以快速、依赖细胞间接触的方式,从另一细胞摄取膜片及其相关分子。本研究考察了肿瘤靶细胞向自然杀伤(NK)细胞转移细胞膜蛋白TYRO3的细胞啃噬现象,以及这一过程对NK细胞功能的影响。

我们发现,NK细胞自身表面不表达TYRO3,但活化的NK细胞可在体外和体内通过细胞啃噬迅速从肿瘤细胞获得TYRO3。获得TYRO3的NK细胞(称为TYRO3+ NK细胞)与TYRO3− NK细胞相比,细胞毒性和IFN产生显著增强,部分活化表面标志物表达也更高。

此外,NK细胞的活化状态及供体细胞(无论是内源还是异位)的TYRO3表达水平均与细胞啃噬程度正相关。作为扩增NK细胞的饲养细胞系,抗原呈递细胞(APC)K562白血病细胞系过表达TYRO3时,该蛋白可经细胞啃噬转移至NK细胞,从而促进NK细胞在体外扩增。这为制造用于治疗癌症或感染性疾病的NK细胞及其工程化衍生细胞(如嵌合抗原受体NK细胞)提供了一种策略。

展开英文摘要原文

Trogocytosis is a fast, cell-cell contact-dependent uptake of membrane patches and associated molecules by one cell from another.

Here, we report our investigation of trogocytosis of TYRO3, a cell membrane protein, from tumor target cells to natural killer (NK) cells and the associated functional consequences for NK cells.

We found that although NK cells did not express endogenous TYRO3 on the cell surface, activated NK cells rapidly acquired TYRO3 from tumor cells via trogocytosis in vitro and in vivo . NK cells that acquired TYRO3, which we termed TYRO3 + NK cells, had significantly enhanced cytotoxicity and IFN production as well as higher expression of some activated surface markers compared with TYRO3 - NK cells.

Furthermore, the activation status of NK cells and TYRO3 expression levels on donor cells, either endogenous or ectopic, positively correlated with trogocytosis levels. When the antigen-presenting cell (APC) K562 leukemia cell line, a feeder cell line to expand NK cells, overexpressed TYRO3, TYRO3 was transferred to NK cells via trogocytosis, which improved NK-cell proliferation ex vivo .

This provides a strategy to manufacture NK cells or their engineered counterparts, such as chimeric antigen receptor NK cells, for the treatment of cancer or infectious diseases.

论文信息

作者
Lu T、Ma R、Li Z、Mansour AG、Teng KY、Chen L、Zhang J、Barr T
第一作者单位
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California.United States
通讯作者单位
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, California. mcaligiuri@coh.org jiayu@coh.org.United States
文献类型
美国 NIH 资助研究 · 非美国政府资助研究
期刊
Cancer immunology research2021 Oct
原文标识
PubMed 34326137 · DOI 10.1158/2326-6066.CIR-20-1014